Histologic and immunohistochemical analyses of α-fetoprotein- producing cancer of the stomach

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 56-65

  Kinjo, Tetsu ^a,b   Taniguchi, Hirokazu ^a   Kushima, Ryoji ^a   Sekine, Shigeki ^a   Oda, Ichiro ^b   Saka, Makoto ^c   Gotoda, Takuji ^b,d   Kinjo, Fukunori ^a,d   Fujita, Jiro ^d   Shimoda, Tadakazu ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

a fetoprotein; enteroblastic type; gastric cancer; glypican 3; hepatoid type

Indexed keywords

ALPHA FETOPROTEIN; GLYPICAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; FEMALE; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84255169828     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31823aafec     Document Type: Article

References (23)

1. Akiyama S, Tamura G, Endoh Y, et al. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma. Int J Cancer. 2006; 106:510-515. (Pubitemid 36966206)
2. Alpert E. Human alpha 1-fetoprotein (AFP): developmental biology and clinical significance. Prog Liver Dis. 1976;5:337-349.
3. Bourreille J, Metayer P, Sauger F, et al. Existence d'alpha fetoproteine au cours d'un cancer secondaire du foie d'origine gastrique. A case report. Cancer. 1985;56:1277-1278.
4. Chang YC, Nagasue N, Kohno H, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol. 1990;85:1480-1485.
5. Fujii H, Ichikawa K, Takagaki T, et al. Genetic evolution of a fetoprotein-producing gastric cancer. J Clin Pathol. 2003;56:942-949. (Pubitemid 37533239)
6. Gitlin D, Perricelli A, Gitlin GM. Synthesis of a-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32:979-982.
7. Hishinuma M, Ohashi K, Yamauchi N, et al. Hepatocellular oncofetal protein, glypican 3, is a sensitive marker for a-fetoprotein-producing gastric carcinoma. Histopathology. 2006;49:479-486. (Pubitemid 44631620)
8. Ishikura H, Fukasawa Y, Ogasawara K, et al. An AFP-producing gastric carcinoma with features of hepatic differentiation: a case report. Cancer. 1985;56:840-848. (Pubitemid 15228278)
9. Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarci-noma of the stomach: an analysis of seven cases. Cancer. 1986; 58:119-126. (Pubitemid 16093113)
10. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 14th ed. Tokyo: Kanehara; 2010.
11. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251-255. (Pubitemid 30489769)
12. Bosman FT, et al. WHO Classification of Tumors of the Digestive System (Gastric carcinoma). Lyon, France: IARC. 2010; 48-63.
13. Kasimura H, Shimoda T, Ikegami M. Phenotypic expression of AFP-producing gastric carcinoma. J Jpn Soc Gastroenterol. 1995;92:751-760. (in Japanese with English abstract).
14. Kodama T, Kameya T, Hirota T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonado-tropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer. 1981;48:1647-1655. (Pubitemid 12199428)
15. Lin YW, Sheu JC, Liu LY, et al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer. 1999;35:1730-1734.
16. Matsunou H, Konishi F, Jalal RE, et al. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer. 1994;73:534-540. (Pubitemid 24046590)
17. Miyayama H, Miyayama Y. Immunohistochemical study of a-FP, CEA, hCG, and plac ALP expressed in human gastrointestinal cancers in comparison to embryo-fetal gastrointestinal mucosa. Pathol Clin Med. 1985;3:905-915.
18. Motoyama T, Aizawa K, Watanabe H, et al. Alpha-fetoprotein-producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn. 1993;43:654-661.
19. Ooi A, Nakanishi I, Sakamoto N, et al. Alpha-fetoprotein(AFP)-producing gastric carcinoma: is it hepatoid differentiation? Cancer. 1990;65:1742-1747.
20. Tsutsumi Y. Differentiation of gastric cancer cells: analysis using immunochemistry and mucin histochemistry. In: Watanabe S, Wolff M, Sommers SC, eds. Digestive Disease Pathology, Vol 1. Philadelphia: Field and Wood; 1988:1-49.
21. Uefuji K, Ichikura T, Tamakuma S. Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers. Jpn J Clin Oncol. 1994;24:135-140.
22. Ushiku T, Uozaki H, Shinozaki A, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear cell, and a-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009;100: 626-632.
23. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocel-lular carcinoma. Mod Pathol. 2005;18:1591-1598. (Pubitemid 41670658)